Erratum (DOI:10.1016/j.bbmt.2006.12.445);Human Progenitor Cells Rapidly Mobilized by AMD3100 Repopulate NOD/SCID Mice with Increased Frequency in Comparison to Cells from the Same Donor Mobilized by Granulocyte Colony Stimulating Factor

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 4, 2007, Pages 398-411

  Hess, David A ^a   Bonde, Jesper ^a   Craft, Timothy C ^a   Wirthlin, Louisa ^a   Hohm, Sarah ^a   Lahey, Ryan ^a   Todt, Laura M ^a   Dipersio, John F ^a   Devine, Steven M ^a   Nolta, Jan A ^a  

^a Hematopoietic Development and Malignancy Group   (United States)

Author keywords

AMD3100; CD34; GCSF; hematopoiesis; NOD SCID transplantation; Stem cell mobilization

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); GRANULOCYTE COLONY STIMULATING FACTOR;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CELL POPULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DILUTION; DONOR; DRUG CLEARANCE; ENGRAFTMENT; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKAPHERESIS; LEUKOCYTE COUNT; MONONUCLEAR CELL; MOUSE; NONHUMAN; STEM CELL MOBILIZATION;

EID: 33947245648     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.04.011     Document Type: Erratum

References (46)

1. Lapidot T., and Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 30 (2002) 973-981
2. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 103 (2004) 1580-1585
3. Bensinger W., Appelbaum F., Rowley S., et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13 (1995) 2547-2555
4. Bensinger W.I., Weaver C.H., Appelbaum F.R., et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85 (1995) 1655-1658
5. Roberts A.W., DeLuca E., Begley C.G., Basser R., Grigg A.P., and Metcalf D. Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. Stem Cells 13 (1995) 512-516
6. Roberts A.W., Foote S., Alexander W.S., Scott C., Robb L., and Metcalf D. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood 89 (1997) 2736-2744
7. Shpall E.J. The utilization of cytokines in stem cell mobilization strategies. Bone Marrow Transplant 23 Suppl 2 (1999) S13-S19
8. Weaver C.H., Hazelton B., Birch R., et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86 (1995) 3961-3969
9. Weaver C.H., Potz J., Redmond J., et al. Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content. Bone Marrow Transplant 19 (1997) 1103-1110
10. Kiss J.E., Rybka W.B., Winkelstein A., et al. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 19 (1997) 303-310
11. Devine S.M., Flomenberg N., Vesole D.H., et al. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin′s lymphoma. J Clin Oncol 22 (2004) 1095-1102
12. Flomenberg N., Devine S.M., Dipersio J.F., et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 106 (2005) 1867-1874
13. Ponomaryov T., Peled A., Petit I., et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 106 (2000) 1331-1339
14. Broxmeyer H.E., Kohli L., Kim C.H., et al. Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol 73 (2003) 630-638
15. Broxmeyer H.E., Cooper S., Kohli L., et al. Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J Immunol 170 (2003) 421-429
16. Lane W.J., Dias S., Hattori K., et al. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 96 (2000) 4152-4159
17. Jo D.Y., Rafii S., Hamada T., and Moore M.A. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest 105 (2000) 101-111
18. Naiyer A.J., Jo D.Y., Ahn J., et al. Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin. Blood 94 (1999) 4011-4019
19. Mohle R., Bautz F., Rafii S., Moore M.A., Brugger W., and Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 91 (1998) 4523-4530
20. Kollet O., Spiegel A., Peled A., et al. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. Blood 97 (2001) 3283-3291
21. Peled A., Petit I., Kollet O., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283 (1999) 845-848
22. Hattori K., Heissig B., Tashiro K., et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97 (2001) 3354-3360
23. Petit I., Szyper-Kravitz M., Nagler A., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3 (2002) 687-694
24. Peled A., Grabovsky V., Habler L., et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J Clin Invest 104 (1999) 1199-1211
25. Peled A., Kollet O., Ponomaryov T., et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95 (2000) 3289-3296
26. Liles W.C., Broxmeyer H.E., Rodger E., et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102 (2003) 2728-2730
27. Liles W.C., Rodger E., Broxmeyer H.E., et al. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion 45 (2005) 295-300
28. Burroughs L., Mielcarek M., Little M.T., et al. Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral blood mononuclear cells in a canine transplantation model. Blood 106 (2005) 4002-4008
29. Broxmeyer H.E., Orschell C.M., Clapp D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201 (2005) 1307-1318
30. Larochelle A., Krouse A., Metzger M., et al. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood 107 (2006) 3772-3778
31. Hess D.A., Meyerrose T.E., Wirthlin L., et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104 (2004) 1648-1655
32. Hess D.A., Wirthlin L., Craft T.P., et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107 (2005) 2162-2169
33. Wang J.C., Doedens M., and Dick J.E. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 89 (1997) 3919-3924
34. Hess D.A., Levac K.D., Karanu F.N., et al. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor. Blood 100 (2002) 869-878
35. Yin A.H., Miraglia S., Zanjani E.D., et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90 (1997) 5002-5012
36. Dick J.E., Bhatia M., Gan O., Kapp U., and Wang J.C. Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells. 15 Suppl 1 (1997) 199-203 [discussion 204-197]
37. Bhatia M., Wang J.C., Kapp U., Bonnet D., and Dick J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A 94 (1997) 5320-5325
38. Civin C.I., Strauss L.C., Brovall C., Fackler M.J., Schwartz J.F., and Shaper J.H. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133 (1984) 157-165
39. Bhatia M., Bonnet D., Kapp U., Wang J.C., Murdoch B., and Dick J.E. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 186 (1997) 619-624
40. Larochelle A., Vormoor J., Hanenberg H., et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 2 (1996) 1329-1337
41. Kahn J., Byk T., Jansson-Sjostrand L., et al. Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 103 (2004) 2942-2949
42. De Clercq E. The bicyclam AMD3100 story. Nat Rev Drug Discov 2 (2003) 581-587
43. Lack N.A., Green B., Dale D.C., et al. A pharmacokinetic-pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100. Clin Pharmacol Ther 77 (2005) 427-436
44. Shepherd R.M., Capoccia B.J., Devine S.M., et al. Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 108 (2006) 3662-3667
45. Huttmann A., Gutersohn A., Noppeney R., Neumann T., Erbel R., and Duhrsen U. Rapid succession of peripheral blood progenitor cell mobilization cycles in patients with chronic heart failure: effects on the hematopoietic system. Transfusion 46 (2006) 1424-1431
46. Bhatia M., Bonnet D., Murdoch B., Gan O.I., and Dick J.E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 4 (1998) 1038-1045